Fecal Microbiota Transplantation is Safe and Effective in Patients with Clostridioides difficile Infection and Cirrhosis

Inflammatory Bowel Disease

Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease

Inflamm Bowel Dis.

Hirten RP, Grinspan A, Fu SC, Luo Y, Suarez-Farinas M, Rowland J, Contijoch EJ, Mogno I, Yang N, Luong T, Labrias PR, Peter I, Cho JH, Sands BE, Colombel JF, Faith JJ, Clemente JC

doi: 10.1093/ibd/izy398.

Gastrointestinal Cancer

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Clin Gastroenterol Hepatol.

Vaughn BP, Rank KM, Khoruts A

doi: 10.1016/j.cgh.2018.07.026.

Hepatology

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

doi: 10.1053/j.gastro.2018.12.005.

Inflammatory Bowel Disease

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Gut

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT

doi: 10.1136/gutjnl-2018-316818.

Hepatology

A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder

Hepatology.

Bajaj JS, Gavis EA, Fagan A, Wade JB, Thacker LR, Fuchs M, Patel S, Davis B, Meador J, Puri P, Sikaroodi M, Gillevet PM

doi: 10.1002/hep.31496.

Further Publications

Clostridioides difficile infection is Associated with Adverse Clinical Outcomes in Patients with Acute Diverticulitis: A Nationwide Study

J Gastroenterol Hepatol

Makar M, Makar G, Xia W, Greenberg P, Patel AV

doi: 10.1111/jgh.15240

Gallbladder and Biliary DiseasesPancreas Diseases

Tacrolimus and Indomethacin are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation

Clin Gastroenterol Hepatol.

Thiruvengadam NR, Forde KA, Chandrasekhara V, Ahmad NA, Ginsberg GG, Khungar V, Kochman ML

doi: 10.1016/j.cgh.2019.10.014.

Inflammatory Bowel Disease

Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence

Am J Gastroenterol.

Lei DK, Ollech JE, Andersen M, Weisshof R, Zmeter N, Sossenheimer P, Rubin DT

doi: 10.14309/ajg.0000000000000460.

HepatitisHepatology

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial

Lancet Gastroenterol Hepatol

Andrieux-Meyer I, Tan SS, Thanprasertsuk S, Salvadori N, Menétrey C, Simon F, Cressey TR, Said HRHM, Hassan MRA, Omar H, Tee HP, Chan WK, Kumar S, Thongsawat S, Thetket K, Avihingsanon A, Khemnark S, Yerly S, Ngo-Giang-Huong N, Siva S, Swanson A, Goyal V, Bompart F, Pécoul B, Murad S

doi: 10.1016/S2468-1253(21)00031-5

Related content

Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder

Clostridioides difficile infection is Associated with Adverse Clinical Outcomes in Patients with Acute Diverticulitis: A Nationwide Study

Tacrolimus and Indomethacin are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation

Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial